Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recombinant, truncated CD4 molecule (rT4) binds IgG.

S Lederman1, M J Yellin, A M Cleary

  • 1Department of Medicine, Columbia University, College of Physicians and Surgeons, New York, NY 10032.

Journal of Immunology (Baltimore, Md. : 1950)
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of Participant Perceptions of Adherence-Related Interactions with Study/Study Team on Drug Levels: HPTN069 Analysis of Self-Reported Adherence Experiences While on Study.

AIDS and behavior·2023
Same author

Interaction of Vasopressin and Splenda on Glucose Metabolism and Long-term Preferences under Ad-libitum and Food-restricted Conditions.

Nutritional neuroscience·2016
Same author

Metabolic scaling and twin placentas.

Placenta·2016
Same author

Measurement of NO Concentration in Water Saturated Nitrogen.

Applied optics·2010
Same author

Antiretroviral therapy; where are we going?

AIDS patient care and STDs·2004
Same author

Combination therapy for patients with HIV-1 infection: the use of dual nucleoside analogues with protease inhibitors and other agents.

AIDS (London, England)·2004
Same journal

Complement C3 deficiency increases the effector and cytotoxic functions of NK cells and suppresses tumor growth.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal

Increased Nur77 is disconnected from TCR affinity in insulin-specific Tregs.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal

FTR85 negatively regulates type I IFN antiviral signaling pathway by promoting K48-linked polyubiquitination of IRF3.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal

An MR1-specific nanobody capable of blocking MR1T cell activation.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal

TGF-β controls developmental fate and functional identity of thymic γδ T cells.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal

Distinguishing Th17 cells as a unique subset.

Journal of immunology (Baltimore, Md. : 1950)·2026
See all related articles

The CD4 molecule, specifically its truncated form (rT4), directly interacts with Immunoglobulin G (IgG) via its Fc region. This binding is specific and not inhibited by anti-CD4 antibodies, suggesting a novel interaction pathway.

Area of Science:

  • Immunology
  • Molecular Biology

Background:

  • CD4 is a T lymphocyte surface glycoprotein crucial for B cell activation.
  • A truncated form of CD4 (rT4) unexpectedly bound to antibodies.

Purpose of the Study:

  • To investigate the interaction between rT4 and Immunoglobulin (Ig) molecules.
  • To determine if CD4 (rT4) specifically binds to IgG.

Main Methods:

  • Enzyme-linked immunosorbent assay (ELISA) to detect binding.
  • Using purified human IgG, myeloma proteins, and different Ig isotypes.
  • Testing binding with aggregated IgG and IgG fragments (Fc and F(ab)2).

Main Results:

  • rT4 demonstrated dose-dependent binding to purified human IgG.

Related Experiment Videos

  • Binding specificity was confirmed for IgG, excluding IgM, IgA, IgD, and beta 2-microglobulin.
  • rT4 bound IgG Fc fragments but not F(ab)2 fragments, and showed increased avidity for aggregated IgG.
  • Conclusions:

    • The CD4 molecule (rT4) specifically interacts with a conserved structure on the IgG Fc region.
    • This interaction is independent of anti-CD4 antibodies and suggests a novel binding mechanism.